Efficacy of Sublingual 5-MeO-DMT for Reducing Anxiety and Depression in MCI

Clinical trial NCT06812221 · COMPLETED

Trial details

NCT number: NCT06812221
Sponsor: Biomind Labs Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment Anxiety State Depression Anxiety Disorder

Start date: 2024-12-15
Primary completion: 2025-02-15
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.